• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION CORPORATION; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2203-45
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 01/29/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional suspect medical device component involved in the event: model number/catalog number: db-2203-45, serial number: (b)(6), batch/lot number: (b)(6), model/catalog description: argyle lead 45cm sterile kit, unique identifier (udi) #: (b)(4).
 
Event or Problem Description
It was reported that the deep brain stimulation (dbs) patient experienced a right sided brain bleed following the dbs implant procedure.Therefore, the patient was hospitalized.The patient is doing well and is expected to fully recover.No further information was able to be obtained despite good faith efforts.
 
Additional Manufacturer Narrative
The devices were not returned as they remain implanted in the patient.As such, physical analysis was unable to be performed.However, it was confirmed the device met manufacturing specifications prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Review of the instructions for use (ifu) confirmed that intracranial hemorrhage is a known risk associated with use of dbs.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.Additional suspect medical device component involved in the event: model number/catalog number: db-2203-45 serial number: (b)(6).Batch/lot number: 5005974 model/catalog description: argyle lead 45cm sterile kit unique identifier (udi) #: (b)(4).
 
Event or Problem Description
It was reported that the deep brain stimulation (dbs) patient experienced a right sided brain bleed following the dbs implant procedure.Therefore, the patient was hospitalized.The patient is doing well and is expected to fully recover.No further information was able to be obtained despite good faith efforts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key24565451
Report Number3006630150-2026-01409
Device Sequence Number9561652
Product Code NHL
UDI-Device Identifier08714729966340
UDI-Public(01)08714729966340(17)271021(10)5006048
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
P150031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/21/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberDB-2203-45
Device Catalogue NumberDB-2203-45
Device Lot Number5006048
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/12/2026
Supplement Date Received by Manufacturer03/31/2026
Initial Report FDA Received Date03/10/2026
Supplement Report FDA Received Date04/21/2026
Date Device Manufactured10/21/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age79 YR
Patient SexMale
-
-